
Nutrition therapy for hepatic conditions and liver disease management.
Liver disease encompasses a spectrum of conditions including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), viral hepatitis, and cirrhosis. Medical nutrition therapy addresses metabolic dysfunction, inflammation, fibrosis progression, and complications such as hepatic encephalopathy and ascites. Nutritional interventions are critical for preventing disease progression and managing complications, with particular focus on weight management, metabolic health, and nutrient optimization.
Implementing weight reduction strategies (5-10% body weight) to reduce hepatic steatosis and improve liver function tests in NAFLD/NASH.
Managing protein intake based on liver function and presence of hepatic encephalopathy (typically 1.2-1.5g/kg for compensated disease).
Addressing micronutrient deficiencies (vitamin D, zinc, B vitamins) common in liver disease through assessment and targeted supplementation.
Sodium and fluid restriction for ascites management and prevention of fluid overload complications.
Fructose and added sugar restriction (<50g/day) shown to reduce hepatic fat accumulation and improve markers of liver disease.
Mediterranean dietary pattern with emphasis on monounsaturated fats, omega-3 fatty acids, and antioxidant-rich foods.
Alcohol elimination or strict limitation depending on liver disease etiology and severity.
Individualized protein and sodium intake based on liver function stage, with adjustments for compensated vs. decompensated cirrhosis.